Fespixon
®
is not approved by the U.S. FDA.
This website is intended for international healthcare professionals outside the U.S. only.
Contact Us
Product
Efficacy
Publication
Knowledge
Education
Training
Video Resources
News
News & Insight
Events
Fespixon
®
is not approved by the U.S. FDA.
This website is intended for international healthcare professionals outside the U.S. only.
Product
Efficacy
Publication
Knowledge
Education
Training
Video Resources
News
News & Insight
Events
Contact Us
Category
Wound Care
Training
,
Wound Care
•
2025-05-27
•
Nelly Wang
Treatment of Diabetic Foot Ulcers
The treatment process for diabetic foot is extremely complex and requires collaboration across multidisciplinary team members.
Read More
Training
,
Wound Care
•
2025-01-17
•
Nelly Wang
Daily Care of Diabetic Foot Ulcers
To effectively prevent the occurrence of foot ulcers, it is essential to engage in proper foot care, undergo regular examinations, and address arterial hardening.
Read More
Recent articles
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Argentina National Administration of Drugs, Foods, and Medical Devices (ANMAT).
2025-10-27
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by COFEPRIS in Mexico.
2025-10-03
The medical device registration application of Bonvadis® for all indications in wounds has been accepted by ThaiFDA.
2025-10-03
2025 International Diabetic Foot Course Form
2025-09-17
Oneness Biotech to participate in the 16th International Diabetic Foot Course 2025
2025-09-12
Expert Talks – Meet Dr. Chia-Ding Shih, DPM on September 5th 1:00 PM at SAWC Fall 2025
2025-09-02
Expert Talks – Meet Dr. Daniel L. Kapp, MD on September 4th 5:30 PM at SAWC Fall 2025
2025-09-02
Search
Search
近期文章
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Argentina National Administration of Drugs, Foods, and Medical Devices (ANMAT).
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by COFEPRIS in Mexico.
The medical device registration application of Bonvadis® for all indications in wounds has been accepted by ThaiFDA.
2025 International Diabetic Foot Course Form
Oneness Biotech to participate in the 16th International Diabetic Foot Course 2025
近期留言
No comments to show.
彙整
October 2025
September 2025
July 2025
June 2025
May 2025
April 2025
March 2025
January 2025
February 2024
November 2023
July 2023
May 2023
April 2023
分類
About
Education
Events
News
Training
Wound Care
Wound Care
